A detailed history of Reliant Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Reliant Investment Partners, LLC holds 3,681 shares of BMY stock, worth $176,209. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,681
Holding current value
$176,209
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

May 20, 2025

BUY
$51.92 - $59.94 $191,117 - $220,639
3,681 New
3,681 $208 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $102B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Reliant Investment Partners, LLC Portfolio

Follow Reliant Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reliant Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reliant Investment Partners, LLC with notifications on news.